PharmEng Technology
United States
44 articles about PharmEng Technology
-
PharmEng Announces Opening Of Montreal Office
4/12/2017
-
PharmEng Announces Opening Of Denver Colorado Office
4/20/2016
-
PharmEng Obtained Court Approval for the Sale of the Consulting Business Assets
7/29/2009
-
PharmEng: Sales Process Initiated for the Assets of PharmEng International Inc., Keata Pharma Inc. and PharmEng Technology Inc.
5/15/2009
-
PharmEng Unable to File Its 2008 Audited Annual Financial Statements and Closes Sydney Manufacturing Facility
4/23/2009
-
PharmEng has Received Notice of Reclassification to Tier 2 Issuer Status
4/21/2009
-
PharmEng has Received Notice of Reclassification to Tier 2 Issuer Status
4/21/2009
-
PharmEng Has Filed Notice of Intention to Make a Proposal Under the Bankruptcy & Insolvency Act (Canada)
4/15/2009
-
PharmEng Announces Resignation of Director
4/14/2009
-
PharmEng Announces Corporate Changes; CEO Takes 50% Salary Reduction
4/13/2009
-
PharmEng to Receive Government Financial Support for Research Into Treatment for Alzheimer's Disease
2/2/2009
-
PharmEng Announces New Supply Agreement With Multi-National Consumer Healthcare Company
1/6/2009
-
PharmEng Announces Organizational Restructuring
12/11/2008
-
PharmEng Reports Reduced Cash Burn, Financing Update, Strategic Update, Board Member Additions, and Third Quarter Earnings for 2008
12/1/2008
-
PharmEng Board Changes
11/7/2008
-
PharmEng CFO Change Announcement
10/6/2008
-
PharmEng Reports Second Quarter Earnings for 2008
8/29/2008
-
PharmEng Receives Site License From Health Canada To Manufacture Natural Health Products In Sydney, Nova Scotia
7/18/2008
-
PharmEng Receives Establishment License From Health Canada for New Facility in Sydney, Nova Scotia
7/8/2008
-
PharmEng Relocates Perth, Ontario Pharmaceutical Contract Manufacturing Operations to New Facility in Sydney, Nova Scotia
6/17/2008